Insulin aspart, recombinant Subcutaneous and Plazomicin Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Plazomicin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: plazomicin
Brand name: Zemdri
Synonyms: Plazomicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Plazomicin Sulfate
- Insulin aspart, recombinant Subcutaneous-Plecanatide
- Insulin aspart, recombinant Subcutaneous-Plegridy
- Insulin aspart, recombinant Subcutaneous-Plegridy Pen
- Insulin aspart, recombinant Subcutaneous-Plegridy Pen Starter Pack
- Insulin aspart, recombinant Subcutaneous-Plegridy Starter Pack
- Plazomicin Intravenous-Insulin degludec
- Plazomicin Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Plazomicin Intravenous-Insulin Degludec (U-100) Vials
- Plazomicin Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Plazomicin Intravenous-Insulin degludec and liraglutide
- Plazomicin Intravenous-Insulin degludec and liraglutide Subcutaneous